Analyst Expects Major Sell-Off for Spotify

Goldman Sachs and Verizon are among the best blue chips at midday

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

MIDDAY MARKET CHECK     6/24/2019
Turn $1,000 into $1.57 Million - with "Holy Grail of Medicine" On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
Dow Edges Up; Gold Pops on U.S.-Iran Tensions By Karee Venema Share On The Dow Jones Industrial Average (DJI) is trading in positive territory at midday, boosted by strong gains for blue chips Goldman Sachs (GS) and Verizon (VZ). The intraday upside is modest, though, as traders take a cautious stance ahead of this week's G-20 meeting between U.S. President Donald Trump and Chinese leader Xi Jinping. And amid simmering geopolitical tensions between Washington and Tehran, gold prices are getting a lift. August-dated gold was last seen up 1.3% at $1,418.80 an ounce, trading near levels not seen since 2013. Continue reading for more on today's market, including:  Why one analyst expects a major sell-off for Spotify. Behind Deere stock's latest pop. Plus, a bullish options bet on big-cap Chinese stocks; BMY swings lower on Otezla news; and Western Digital trades near the top of the S&P. >> Continue reading...
LATEST HEADLINES
>> AVAV Stock Could Be Set for Big Earnings Move AeroViroment is slated to release its second-quarter earnings after the close tomorrow >> Analyst: This Coffee Chain is "Underappreciated" Puts have been hot on outperforming DNKN lately >> Twinkies Stock Tests Pivotal Chart Level Hostess Brands just received its third bull note this month >> AXTA Stock Runs Higher Amid Board Shake-Up, Jana Buzz Axalta's chairman of the board just stepped down from his position >> Evercore Slams Spotify Stock With Scathing Bear Note The brokerage firm downgraded SPOT, and slashed its price target ADVERTISEMENT The #1 Biotech Stock to Own Today On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
To ensure delivery of Schaeffer's Midday Market Check, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Midday Market Check or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Midday Market Check? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S MIDDAY MARKET CHECK enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com